| For: |
Guo CY, Xu XF, Wu JY, Liu SF. PCR-SSCP-DNA sequencing method in detecting |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3804.htm |
| Number | Citing Articles |
| 1 |
Maisa Yoshimoto, Olga Ludkovski, Dave DeGrace, Julia L. Williams, Andrew Evans, Kanishka Sircar, Tarek A. Bismar, Paulo Nuin, Jeremy A. Squire. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes, Chromosomes and Cancer 2012; 51(2) doi: 10.1002/gcc.20939
|
| 2 |
Gang Li, Zhiguo Zhang, Jianghong Zhang, Tianbo Jin, Hongjuan Liang, Li Gong, Guangbin Cui, Haixia Yang, Shiming He, Yongsheng Zhang, Guodong Gao. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-17
|
| 3 |
Hasibe Cingilli Vural. PCR-SSCP-DNA Sequencing Method in DetectingPTENGene Mutation and its Significance in Human Breast Cancer in Turkish Populations. Biotechnology & Biotechnological Equipment 2012; 26(5) doi: 10.5504/BBEQ.2012.0084
|
| 4 |
Asgar Ali, Pramod Kumar Mishra, Sadhana Sharma, Asit Arora, Sundeep Singh Saluja. Effects of PTEN gene alteration in patients with gallbladder cancer. Cancer Genetics 2015; 208(12) doi: 10.1016/j.cancergen.2015.09.007
|
| 5 |
Sormeh Mina, Benjamin A Bohn, Ronald Simon, Antje Krohn, Matthias Reeh, Dirk Arnold, Carsten Bokemeyer, Guido Sauter, Jakob R Izbicki, Andreas Marx, Phillip R Stahl. PTEN deletion is rare but often homogeneous in gastric cancer. Journal of Clinical Pathology 2012; 65(8) doi: 10.1136/jclinpath-2011-200525
|
| 6 |
Saleh Azadbakht, Parastoo Baharvand, Mojgan Saki, Alireza Moayyedkazemi. Gastric Cancer: A Review of Risk Factors and New Insights into
Treatment. Current Cancer Therapy Reviews 2023; 19(1) doi: 10.2174/1573394718666220428105301
|
| 7 |
QIUFENG QI, YANG LING, MING ZHU, LINYAN ZHOU, MEIZHEN WAN, YANQING BAO, YONGPING LIU. Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer. Biomedical Reports 2014; 2(5) doi: 10.3892/br.2014.298
|
| 8 |
Emel Canbay, Ozlem T. Kahraman, Dursun Bugra, Burcu Caykara, M. Fatih Seyhan, Turker Bulut, Sumer Yamaner, Oguz Ozturk. Increased Gastric Cancer Risk withPTENIVS4 Polymorphism in a Turkish Population. Genetic Testing and Molecular Biomarkers 2013; 17(3) doi: 10.1089/gtmb.2012.0306
|
| 9 |
Roopma Wadhwa, Shumei Song, Ju-Seog Lee, Yixin Yao, Qingyi Wei, Jaffer A. Ajani. Gastric cancer—molecular and clinical dimensions. Nature Reviews Clinical Oncology 2013; 10(11) doi: 10.1038/nrclinonc.2013.170
|
| 10 |
Liang Yin, Yunzhao chen, Wenting Li, Benlin Hua, Jinfang Jiang, Hongan Li, Feng Li. Mutational analysis of the PTEN gene in soft tissue sarcomas. The Chinese-German Journal of Clinical Oncology 2010; 9(7) doi: 10.1007/s10330-010-0647-9
|
| 11 |
Asgar Ali, Sundeep S. Saluja, Krishnan Hajela, Pramod K. Mishra, Moshahid A. Rizvi. Mutational and expressional analyses of PTEN gene in colorectal cancer from Northern India. Molecular Carcinogenesis 2014; 53(S1) doi: 10.1002/mc.22001
|
| 12 |
M. Moshahid Alam Rizvi, M. Shabbir Alam, Asgar Ali, Syed Jafar Mehdi, Swaraj Batra, A. K. Mandal. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. Journal of Cancer Research and Clinical Oncology 2011; 137(8) doi: 10.1007/s00432-011-0994-0
|
| 13 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 14 |
Rutvi Agrawal, Priyanka Jurel, Akash Garg, Bhupendra G. Prajapati, Sumel Ashique. Advances in Gastric Cancer Management: Signaling Pathways, Emerging Diagnostic and Therapeutic Strategies. Cancer Biotherapy and Radiopharmaceuticals 2026; 41(5) doi: 10.1177/10849785251408598
|
| 15 |
MIN LI, HUAWEN SUN, LUJUN SONG, XIAODONG GAO, WENJU CHANG, XINYU QIN. Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma. Oncology Letters 2012; 4(6) doi: 10.3892/ol.2012.930
|
| 16 |
Guifang Du, Yanan Gu, Chengcheng Hao, Zhu Yuan, Junqi He, Wen G. Jiang, Shan Cheng. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Oncotarget 2016; 7(20) doi: 10.18632/oncotarget.8751
|